Lehrstuhl für Innere Medizin V

TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection (2016) Schleicher U, Paduch K, Debus A, Obermeyer S, Koenig T, Kling JC, Ribechini E, et al. Journal article LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells (2016) Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, et al. Journal article Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma (2016) Crump M, Leppa S, Fayad L, Lee JJ, Di Rocco A, Ogura M, Hagberg H, et al. Journal article Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment (2016) Chevalier N, Mueller M, Mougiakakos D, Ihorst G, Marks R, Schmitt-Graeff A, Veelken H Journal article Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells (2016) Henrich F, Singer K, Poller K, Bernhardt L, Strobl C, Limm K, Ritter AP, et al. Journal article The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia (2016) Qorraj M, Bruns H, Böttcher M, Weigand L, Saul D, Mackensen A, Jitschin R, Mougiakakos D Journal article Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation (2016) Böttcher M, Hofmann AD, Bruns H, Haibach M, Loschinski R, Saul D, Mackensen A, et al. Journal article Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus (2016) Gerstner S, Köhler W, Heidkamp GF, Purbojo A, Uchida S, Ekici AB, Heger L, et al. Journal article Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment (2016) Heidkamp GF, Sander J, Lehmann C, Heger L, Eissing N, Baranska A, Lühr J, et al. Journal article Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study (2016) Goebeler ME, Knop S, Viardot A, Kufer P, Topp MS, Einsele H, Noppeney R, et al. Journal article